Antiviral Treatments for coronavirus eligibility criteria
Patients must meet all the eligibility criteria and none of the exclusion criteria. Pre-hospitalised patients are eligible to be considered if:
- SARS-CoV-2 infection is confirmed by polymerase chain reaction (PCR) testing within the last 72 hours or
- SARS-CoV-2 infection is confirmed by formally registered positive lateral flow testing (LFT) within the last 72 hours and
- Onset of symptoms of COVID-192 3 within the last 7 days
‘Highest’ risk group
The following patient cohorts were determined by an independent advisory group commissioned by the Department of Health and Social Care (DHSC)
- Down’s syndrome and other genetic disorders
- Sickle cell disease
- Patients with a solid cancer
- Patients with a haematologic malignancy
- Patients with renal disease
- Patients with liver disease
- Patients with immune-mediated inflammatory disorders (IMID)
- Primary immune deficiencies
- HIV/AIDS
- Solid organ transplant recipients or Rare neurological conditions.